• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

负载(烷基-ω-醇)三苯基锡(IV)的介孔二氧化硅作为具有生物相容性的潜在神经保护剂:对与阿尔茨海默病病理生理学相关酶的抑制活性评估

(Alkyl-ω-ol)triphenyltin(IV)-Loaded Mesoporous Silica as Biocompatible Potential Neuroprotectors: Evaluation of Inhibitory Activity Against Enzymes Associated with the Pathophysiology of Alzheimer's Disease.

作者信息

Milisavljević Kristina, Milanović Žiko, Matić Jovana, Antonijević Marko, Simić Vladimir, Milošević Miljan, Kosanić Marijana, Kaluđerović Goran N

机构信息

Institute for Information Technologies, University of Kragujevac, Jovana Cvijića bb, 34000 Kragujevac, Serbia.

Department of Chemistry, Faculty of Science, University of Kragujevac, Radoja Domanovića 12, 34000 Kragujevac, Serbia.

出版信息

Nanomaterials (Basel). 2025 Jun 12;15(12):914. doi: 10.3390/nano15120914.

DOI:10.3390/nano15120914
PMID:40559280
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12195829/
Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by synaptic dysfunction and neuronal loss due to the accumulation of amyloid-β peptides and tau proteins. In the pursuit of novel neuroprotective strategies, organotin(IV) compounds have garnered attention due to their unique chemical and biological properties. This study evaluates the inhibitory potential of two triphenyltin(IV) derivatives-(3-propan-1-ol)triphenyltin(IV) () and (4-butan-1-ol)triphenyltin(IV) ()-in both free form and immobilized into mesoporous silica SBA-15~Cl, targeting acetylcholinesterase (), a key enzyme involved in AD pathophysiology. The nanostructures exhibited the most potent inhibitory activity against (IC = 0.58 μM), significantly outperforming the standard drug galantamine. Molecular docking, molecular dynamics simulations, and MM/GBSA and MM/PBSA analyses confirmed the stability and selectivity of interactions with , primarily driven by hydrophobic interactions. Compound transport was also simulated using a multi-scale 3D mouse brain model to evaluate brain tissue distribution and blood-brain barrier permeability. The results highlight the strong potential of SBA-15-loaded organotin(IV) compounds as biocompatible neuroprotective agents for novel treatments of neurodegenerative diseases.

摘要

阿尔茨海默病(AD)是一种进行性神经退行性疾病,其特征是由于淀粉样β肽和tau蛋白的积累导致突触功能障碍和神经元丧失。在寻求新型神经保护策略的过程中,有机锡(IV)化合物因其独特的化学和生物学特性而受到关注。本研究评估了两种三苯基锡(IV)衍生物——(3-丙醇)三苯基锡(IV)()和(4-丁醇)三苯基锡(IV)()——以游离形式以及固定在介孔二氧化硅SBA-15~Cl中的形式,针对乙酰胆碱酯酶()的抑制潜力,乙酰胆碱酯酶是AD病理生理学中的一种关键酶。该纳米结构对乙酰胆碱酯酶表现出最有效的抑制活性(IC = 0.58 μM),显著优于标准药物加兰他敏。分子对接、分子动力学模拟以及MM/GBSA和MM/PBSA分析证实了与乙酰胆碱酯酶相互作用的稳定性和选择性,主要由疏水相互作用驱动。还使用多尺度三维小鼠脑模型模拟了化合物转运,以评估脑组织分布和血脑屏障通透性。结果突出了负载SBA-15的有机锡(IV)化合物作为生物相容性神经保护剂用于神经退行性疾病新治疗的强大潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c82e/12195829/779d62ac2345/nanomaterials-15-00914-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c82e/12195829/c4e37d0e79ee/nanomaterials-15-00914-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c82e/12195829/abb3a6d16e79/nanomaterials-15-00914-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c82e/12195829/17336a624fa2/nanomaterials-15-00914-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c82e/12195829/585786766a1f/nanomaterials-15-00914-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c82e/12195829/0b300e982f03/nanomaterials-15-00914-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c82e/12195829/7880938ccac7/nanomaterials-15-00914-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c82e/12195829/779d62ac2345/nanomaterials-15-00914-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c82e/12195829/c4e37d0e79ee/nanomaterials-15-00914-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c82e/12195829/abb3a6d16e79/nanomaterials-15-00914-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c82e/12195829/17336a624fa2/nanomaterials-15-00914-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c82e/12195829/585786766a1f/nanomaterials-15-00914-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c82e/12195829/0b300e982f03/nanomaterials-15-00914-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c82e/12195829/7880938ccac7/nanomaterials-15-00914-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c82e/12195829/779d62ac2345/nanomaterials-15-00914-g007.jpg

相似文献

1
(Alkyl-ω-ol)triphenyltin(IV)-Loaded Mesoporous Silica as Biocompatible Potential Neuroprotectors: Evaluation of Inhibitory Activity Against Enzymes Associated with the Pathophysiology of Alzheimer's Disease.负载(烷基-ω-醇)三苯基锡(IV)的介孔二氧化硅作为具有生物相容性的潜在神经保护剂:对与阿尔茨海默病病理生理学相关酶的抑制活性评估
Nanomaterials (Basel). 2025 Jun 12;15(12):914. doi: 10.3390/nano15120914.
2
Galantamine for Alzheimer's disease.加兰他敏用于治疗阿尔茨海默病。
Cochrane Database Syst Rev. 2002(3):CD001747. doi: 10.1002/14651858.CD001747.
3
Galantamine for Alzheimer's disease.加兰他敏用于治疗阿尔茨海默病。
Cochrane Database Syst Rev. 2001(4):CD001747. doi: 10.1002/14651858.CD001747.
4
Physostigmine for Alzheimer's disease.用于治疗阿尔茨海默病的毒扁豆碱。
Cochrane Database Syst Rev. 2001;2001(2):CD001499. doi: 10.1002/14651858.CD001499.
5
18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).使用氟代甲磺酸去甲肾上腺素的18F正电子发射断层显像用于轻度认知障碍(MCI)患者中阿尔茨海默病性痴呆及其他痴呆的早期诊断。
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012884. doi: 10.1002/14651858.CD012884.
6
Galantamine for Alzheimer's disease and mild cognitive impairment.加兰他敏用于治疗阿尔茨海默病和轻度认知障碍。
Cochrane Database Syst Rev. 2006 Jan 25;2006(1):CD001747. doi: 10.1002/14651858.CD001747.pub3.
7
Cholinesterase inhibitors for Alzheimer's disease.用于治疗阿尔茨海默病的胆碱酯酶抑制剂。
Cochrane Database Syst Rev. 2006 Jan 25;2006(1):CD005593. doi: 10.1002/14651858.CD005593.
8
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
10
Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review.多奈哌齐、卡巴拉汀和加兰他敏治疗阿尔茨海默病的临床疗效及成本效益:一项快速系统评价
Health Technol Assess. 2001;5(1):1-137. doi: 10.3310/hta5010.

本文引用的文献

1
Urolithin D: A promising metabolite of ellagitannin in combatting oxidative stress.尿石素D:一种在对抗氧化应激方面颇具潜力的鞣花单宁代谢产物。
Chem Biol Interact. 2025 Apr 25;411:111444. doi: 10.1016/j.cbi.2025.111444. Epub 2025 Feb 21.
2
Theoretical Study of Antioxidant and Prooxidant Potency of Protocatechuic Aldehyde.原儿茶醛抗氧化及促氧化能力的理论研究
Int J Mol Sci. 2025 Jan 5;26(1):404. doi: 10.3390/ijms26010404.
3
Copper(II) and Zinc(II) Complexes with Bacterial Prodigiosin Are Targeting Site III of Bovine Serum Albumin and Acting as DNA Minor Groove Binders.
细菌血晶素铜(II)和锌(II)配合物靶向牛血清白蛋白 III 位点并充当 DNA 小沟结合物。
Int J Mol Sci. 2024 Aug 1;25(15):8395. doi: 10.3390/ijms25158395.
4
Ceanothanes Derivatives as Peripheric Anionic Site and Catalytic Active Site Inhibitors of Acetylcholinesterase: Insights for Future Drug Design.作为外周阴离子部位和乙酰胆碱酯酶催化活性部位抑制剂的美洲茶衍生物:对未来药物设计的启示。
Int J Mol Sci. 2024 Jul 3;25(13):7303. doi: 10.3390/ijms25137303.
5
New insights into butyrylcholinesterase: Pharmaceutical applications, selective inhibitors and multitarget-directed ligands.对丁酰胆碱酯酶的新认识:药物应用、选择性抑制剂和多靶点导向配体。
Eur J Med Chem. 2024 Sep 5;275:116569. doi: 10.1016/j.ejmech.2024.116569. Epub 2024 Jun 4.
6
ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support.ADMETlab 3.0:一个更新的全面在线 ADMET 预测平台,具有更广泛的覆盖范围、更高的性能、API 功能和决策支持。
Nucleic Acids Res. 2024 Jul 5;52(W1):W422-W431. doi: 10.1093/nar/gkae236.
7
AmberTools. AmberTools。
J Chem Inf Model. 2023 Oct 23;63(20):6183-6191. doi: 10.1021/acs.jcim.3c01153. Epub 2023 Oct 8.
8
Green synthesis of benzimidazole derivatives by using zinc boron nitride catalyst and their application from DFT (B3LYP) study.使用氮化锌硼催化剂绿色合成苯并咪唑衍生物及其基于密度泛函理论(B3LYP)研究的应用
Heliyon. 2022 Nov 8;8(11):e11480. doi: 10.1016/j.heliyon.2022.e11480. eCollection 2022 Nov.
9
Recent advance on pleiotropic cholinesterase inhibitors bearing amyloid modulation efficacy.具有淀粉样蛋白调节作用的多功能胆碱酯酶抑制剂的最新进展。
Eur J Med Chem. 2022 Nov 15;242:114695. doi: 10.1016/j.ejmech.2022.114695. Epub 2022 Aug 27.
10
Effect of chain length on the cytotoxic activity of (alkyl-ω-ol)triphenyltin(IV) loaded into SBA-15 nanostructured silica and in vivo study of SBA-15~Cl|PhSn(CH)OH.链长对负载于 SBA-15 纳米结构二氧化硅的(烷基-ω-醇)三苯基锡(IV)的细胞毒性活性的影响及 SBA-15~Cl|PhSn(CH)OH 的体内研究。
Biomater Adv. 2022 Sep;140:213054. doi: 10.1016/j.bioadv.2022.213054. Epub 2022 Jul 30.